Fundraising FoxIllumentx
1 known investors
Find your way into Illumentx
Sign up to see every warm intro you have to Illumentx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Illumentx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Illumen Therapeutics is a biotech company developing first-in-class PARN inhibitor drugs that increase functional p53, a tumor suppressor, as a treatment for aggressive cancers. Its drug development focuses on targeting p53 dysregulation to improve cancer patient survival.
Investors · 1
Frequently asked questions
- What does Illumentx do?
- Illumen Therapeutics is a biotech company developing first-in-class PARN inhibitor drugs that increase functional p53, a tumor suppressor, as a treatment for aggressive cancers. Its drug development focuses on targeting p53 dysregulation to improve cancer patient survival.
- Who are Illumentx's investors?
- Illumentx's investors include Colorado BioScience Association.